Dec 4, 2023

Volume 19 Number 10

In this issue an expert consensus from the Bifurcation Academic Research Consortium on the definitions and standardised endpoints for the treatment of coronary bifurcations. In coronary interventions: the impact of P2Y12 de-escalation in high bleeding risk patients; the 5-year outcomes of the TARGET All Comers trial of patients treated with either the FIREHAWK biodegradable-polymer sirolimus-eluting stent or a durable-polymer everolimus-eluting stent; the use of the tip-in and rendezvous techniques in the PROGRESS-CTO registry; the PATCATH survey on patients undergoing either elective or in-patient coronary angiography or PCI. In interventions for valvular disease and heart failure: cardiac damage staging classifications across the haemodynamic spectrum of severe aortic stenosis. Viewpoints on AI-assisted cardiology and contradictory RCT results; and more.


Towards AI-assisted cardiology: a reflection on the performance and limitations of using large language models in clinical decision-making
Salihu A, Gadiri MA, Skalidis I, Meier D, Auberson D, Fournier A, Fournier R, Thanou D, Abbé E, Muller O, Fournier S

Coronary interventions

Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M, Louvard Y, Lefèvre T, Stankovic G, Burzotta F, Kassab G, Lassen J, Darremont O, Garg S, Koo B, Holm N, Johnson T, Pan M, Chatzizisis Y, Banning A, Chieffo A, Dudek D, Hildick-Smith D, Garot J, Henry T, Dangas G, Stone GW, Krucoff M, Cutlip D, Mehran R, Wijns W, Sharif F, Serruys PW, Onuma Y
De-escalation from ticagrelor to clopidogrel in patients with acute myocardial infarction: the TALOS-AMI HBR substudy
Kim MC, Ahn SG, Cho KH, Sim DS, Hong YJ, Kim JH, Jeong MH, Lee J, Youn Y, Kim H, Yoo K, Jeon D, Shin E, Jeong Y, Chang K, Ahn Y
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent – five-year results of the TARGET All Comers randomised clinical trial
Lansky AJ, Xu B, Baumbach A, Kelbæk H, van Royen N, Zheng M, Knaapen P, Slagboom T, Johnson T, Vlachojannis GJ, Arkenbout KE, Holmvang L, Janssens L, Brugaletta S, Naber CK, Schmitz T, Anderson R, Rittger H, Berti S, Barbato E, Toth GG, Maillard L, Valina CM, Buszman PE, Thiele H, Schächinger V, Wijns W

Editorial comment

Polymers, thickness, dosage: just pieces of the whole puzzle
Paradies V, Maurina M
The tip-in and rendezvous techniques in retrograde chronic total occlusion percutaneous coronary interventions
Allana S, Rempakos A, Kostantinis S, Alexandrou M, Mutlu D, Alaswad K, Azzalini L, Kearney K, Krestyaninov O, Khelimskii D, Gorgulu S, Chandwaney R, Jaffer F, Khatri J, Davies R, Benton S, Choi J, Karmpaliotis D, Poommipanit P, Nicholson W, Jaber W, Rinfret S, Frizzel J, Patel T, Jefferson B, Aygul N, Goktekin O, ElGuindy A, Abi-Rafeh N, Rangan B, Burke MN, Sandoval Y, Brilakis E
Initial findings with the PATient experience in the CATH Lab (PATCATH) patient-reported experience metric
Fitzgerald S, Wilson H, Brenan M, Rai H, Begossi N, Blake N, McCann H, Blake G, Colleran R, Hanratty C, Byrne RA

Interventions for valvular disease and heart failure

Prognostic impact of cardiac damage staging classification in each aortic stenosis subtype undergoing TAVI
Nakase M, Okuno T, Tomii D, Alaour B, Praz F, Stortecky S, Lanz J, Reineke D, Windecker S, Pilgrim T

Editorial comment

TAVI in a patient with a double-lumen aortic arch
Tsioufis K, Dimitriadis K, Aznaouridis K, Aggeli K
Receive our newsletter

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved